Apr 10, 2025 08:30AM

Mar 4, 2024 08:04AM

Mar 4, 2024 08:00AM

Feb 28, 2024 04:45PM

Feb 21, 2024 10:36PM

Feb 21, 2024 05:43PM

Feb 12, 2024 08:55AM Gilead Sciences (GILD) to acquire CymaBay Therapeutics (CBAY) in $4.3bn cash deal

Feb 12, 2024 08:45AM

Feb 12, 2024 08:45AM

Feb 12, 2024 08:42AM

Feb 12, 2024 08:32AM

Feb 12, 2024 08:30AM

Jan 31, 2024 08:00AM

Dec 15, 2023 08:00AM CymaBay Therapeutics (CBAY) Submits NDA for Seladelpar for the Treatment of Primary Biliary Cholangitis

Dec 15, 2023 08:00AM

Nov 13, 2023 08:00AM

Nov 7, 2023 04:04PM

Oct 23, 2023 08:09AM

Oct 23, 2023 08:00AM

Sep 7, 2023 07:02AM

Sep 7, 2023 07:00AM CymaBay's Seladelpar Achieves High Statistical Significance for the Primary and Key Secondary Endpoints in the Phase 3 RESPONSE Trial in Primary Biliary Cholangitis

Apr 21, 2023 08:02AM

Apr 21, 2023 08:00AM

Jun 21, 2021 08:00AM

Jun 9, 2021 08:00AM

May 6, 2021 08:00AM

Apr 5, 2021 08:00AM

Mar 25, 2021 04:10PM CymaBay Reports Fourth Quarter and Year End 2020 Financial Results and Provides Corporate Update

Mar 12, 2021 08:00AM

Mar 11, 2021 08:00AM

Mar 9, 2021 07:19AM

Feb 24, 2021 08:00AM

Feb 10, 2021 08:00AM

Nov 16, 2020 04:01PM

Nov 11, 2020 08:00AM CymaBay Therapeutics to Present at Upcoming Investor Conferences

Nov 5, 2020 04:05PM

Nov 2, 2020 08:08AM

Nov 2, 2020 08:00AM

Oct 30, 2020 04:32PM

Oct 1, 2020 08:00AM

Sep 3, 2020 04:05PM

Aug 27, 2020 08:04AM CymaBay Therapeutics (CBAY) Highlights Positive Final Results from 52-Week Phase 2 Study in Primary Biliary Cholangitis

Aug 27, 2020 08:00AM

Aug 20, 2020 08:00AM

Aug 11, 2020 08:07AM

Aug 10, 2020 04:01PM

Aug 3, 2020 04:01PM

Aug 3, 2020 01:18PM

Aug 3, 2020 07:06AM CymaBay Therapeutics (CBAY) Announces Positive Topline Results from ENHANCE for Seladelpar in Patients with Primary Biliary Cholangitis

Aug 3, 2020 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All